You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 15, 2024

Watson Labs Teva Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?

WATSON LABS TEVA has fifty approved drugs.

There are two tentative approvals on WATSON LABS TEVA drugs.

Summary for Watson Labs Teva

US Patents:	0
Tradenames:	44
Ingredients:	42
NDAs:	50

Drugs and US Patents for Watson Labs Teva

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs Teva	MINOCYCLINE HYDROCHLORIDE	minocycline hydrochloride	CAPSULE;ORAL	063181-001	Dec 30, 1991	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Watson Labs Teva	ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE	albuterol sulfate; ipratropium bromide	SOLUTION;INHALATION	077063-001	Dec 31, 2007		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Watson Labs Teva	LURASIDONE HYDROCHLORIDE	lurasidone hydrochloride	TABLET;ORAL	208016-004	Feb 2, 2021		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Watson Labs Teva	LURASIDONE HYDROCHLORIDE	lurasidone hydrochloride	TABLET;ORAL	208016-002	Feb 2, 2021		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Watson Labs Teva	CINACALCET HYDROCHLORIDE	cinacalcet hydrochloride	TABLET;ORAL	204377-002	Dec 27, 2018	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Watson Labs Teva	TEMOZOLOMIDE	temozolomide	CAPSULE;ORAL	203959-005	Apr 18, 2017		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Watson Labs Teva	TEMOZOLOMIDE	temozolomide	CAPSULE;ORAL	203959-002	Apr 18, 2017		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for WATSON LABS TEVA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.